The WHO classification of Tumors of the CNS was updated in 2016 to include molecular status for identifying diffuse gliomas, such as IDH gene mutation and chromosomal 1p/19q codeletion (9). The gene discussed is IDH1; the disease is central nervous system neoplasm.